NMPA Releases 67th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 67th batch of reference drugs for...
Jiangsu Hengrui Pharmaceuticals Advances SHR-1819, SHR-2002, and Adebrelimab into New Clinical Trials
Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276) has announced receiving clinical trial approvals for its...
Ascletis Pharma Receives Approval for Phase IIa Study of ASC10 for RSV Infection
China-based Ascletis Pharma Inc. (HKG: 1672) has announced receiving the green light to conduct a...
EQRx Inc. Abandons Plans for Low-Cost Drugs, Terminates Development of Three China-Sourced Products
US-based biotech EQRx Inc., (Nasdaq: EQRX) has disclosed in its Q4 2022 financial report a...
Shunxi Holding Group Secures Licensing Deal for Cartherics’ CTH-004 in Greater China
China-based Shunxi Holding Group Co. Ltd has entered into a licensing deal with Australia-based firm...
AstraZeneca’s MEK Inhibitor Koselugo Approved in China for Pediatric NF1-Related PN
UK major AstraZeneca (AZ, NASDAQ: AZN) has announced that its mitogen-activated protein kinase (MEK) inhibitor,...
Shenzhen’s Angio8 Secures Tens of Millions in Series A Financing for Surgical Robot Development
Angio8, a Shenzhen-based developer of vascular interventional surgical robots, has reportedly raised tens of millions...
BeiGene’s Brukinsa Receives NMPA Approval for Expanded Use in Leukemia and Lymphoma
China-based BeiGene (NASDAQ: BGNE, HKG: 6160, SHA: 688235) has announced that it has received approval...
Shanghai Junshi Biosciences’ Tuoyi Shows Promise in Phase III Study for ES-SCLC
Shanghai Junshi Biosciences Co., Ltd (HKG: 1877, SHA: 688180) has announced encouraging results from the...
Tianjin, Shandong, and Hainan Provinces Announce VBP Backup Suppliers for Round 8
Tianjin, Shandong, and Hainan provinces in China have released their lists of backup suppliers following...
Suzhou GenAssist’s GEN6050 Receives US FDA Pre-IND Acceptance for Duchenne Muscular Dystrophy Treatment
China-based Suzhou GenAssist Therapeutic Co., Ltd has announced that the US Food and Drug Administration...
Sinopharm Partners with Fudan University to Establish National Innovation Platform
China National Pharmaceutical Group Corporation (Sinopharm, HKG: 1099) has announced a strategic partnership with Fudan...
Reistone Biopharma’s Edralbrutinib Earns Orphan Drug Designation for NMOSD from US FDA
Reistone Biopharma Co., Ltd, a company incubated by Hengrui Medicine with an investment of USD...
Lingyi Biotechnology Secures RMB 100 Million in Series A Funding for Gene Therapy Pipeline
China-based gene therapy developer Lingyi Biotechnology Co., Ltd has reportedly raised close to RMB 100...
Henlius Biotech’s HLX26 and HaiSiZhuang Combo for NSCLC Gets NMPA Phase II Approval
Shanghai Henlius Biotech (HKG: 2696) has announced that it has received approval from the National...
Shanghai Junshi Biosciences Inks Exclusive License Deal with Dr. Reddy’s Laboratories for Tuoyi
Shanghai Junshi Biosciences Co., Ltd (SHA: 688180), a China-based biotechnology firm, has announced an exclusive...
Sinopharm Partners with Shenzhen to Boost High-End Medical Device and Pharmaceutical Innovation
China National Pharmaceutical Group Corporation (Sinopharm, HKG: 1099) has announced a strategic partnership with Shenzhen...
XtalPi Inc. and China Pharmaceutical University Launch Joint AI Research Center in China
Sino-US artificial intelligence (AI) firm XtalPi Inc. has joined forces with China Pharmaceutical University (CPU)...
Omega Medical Imaging’s Soteria.AI Receives FDA Approval for Interventional Cardiology
US-based medical technology firm Omega Medical Imaging has received marketing approval from the US Food...
NMPA Extends Public Feedback Period for ‘Drug Standardization Management Measures’ in China
The National Medical Products Administration (NMPA) in China has announced an extension to the public...